DiscoverTalk of HopeLet's Talk About Lung Cancer | S1, Ep2: Biomarker testing and genetically-driven lung cancers
Let's Talk About Lung Cancer | S1, Ep2: Biomarker testing and genetically-driven lung cancers

Let's Talk About Lung Cancer | S1, Ep2: Biomarker testing and genetically-driven lung cancers

Update: 2023-01-23
Share

Description

Lorraine Dallas, our director of prevention, information and support, chats to consultant oncologist Dr David Gilligan and Peter Cowley, who is living with advanced stage lung cancer.


Therapies are available for some lung cancers driven by genetic mutations or rearrangements, which is why biomarker testing is so important. Peter shares his experience of diagnosis and being eligible for one of these medicines.


For more information about lung cancer and Roy Castle Lung Cancer Foundation, visit roycastle.org.


Keep up to date with the latest news by following our social media channels:


Twitter - Roy_Castle_Lung


Instagram - RoyCastleLungCancer 


Facebook - Roy Castle Lung Cancer Foundation

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Let's Talk About Lung Cancer | S1, Ep2: Biomarker testing and genetically-driven lung cancers

Let's Talk About Lung Cancer | S1, Ep2: Biomarker testing and genetically-driven lung cancers

Roy Castle Lung Cancer Foundation